Doctor Peter Jirak

C - reactive protein is a promising indicator of ventricular arrhythmias in pacemaker patients

Event: ESC Acute CardioVascular Care 2022

Topic: Clinical

Session: e-Posters session

Access

0

Higher incidence of stroke in severe COVID-19 is not associated with a higher burden of arrhythmias: Comparison to other types of severe pneumonia

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Arrhythmias e-posters

Access

0

Changes in micro-RNA secretion patterns following an anti-CD3 and ATG treatment regulate expression of adherens junctions in PBMCs

Event: Heart Failure 2021 Online Congress

Topic: Diabetes and the Heart

Session: ePoster session

Access

0

Analysis of novel cardiac markers sST2 and IL-33 in chronic heart failure with reduced ejection fraction

Event: ESC CONGRESS 2019

Topic: Biomarkers

Session: Molecular mechanisms of cardiovascular inflammation

Access

0

Differences in the expression of the novel cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in HFpEF, ICM and DCM patients

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods

Access

0

A comparative analysis of novel biomarkers in sepsis and cardiovascular disease

Event: Acute Cardiovascular Care 2019

Topic: Biomarkers

Session: Moderated Poster 7: Acute Coronary Syndromes II

Access

0

A comparative analysis of the novel cardiac biomarkers sST2, GDF-15, Galectin-3, suPAR, H-FABP and Fetuin-A in heart failure, STEMI and NSTEMI patients

Event: ESC Congress 2018

Topic: Biomarkers

Session: Chronic heart failure – Diagnostic methods

Access

0

A comparative analysis of novel cardiac biomarkers (sST2, GDF-15, Galectin-3, suPAR, H-FABP and Fetuin-A) in patients with heart failure, STEMI and controls without cardiovascular disease

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods

Access

0

Analysis of the novel cardiac biomarkers ST2, GDF-15, suPAR, H-FABP and Fetuin A in heart failure with reduced ejection fraction

Event: ESC CONGRESS 2017

Topic: Diagnosis

Session: Heart failure - Diagnostic assessment

Access

0

Analysis of the novel cardiac biomarkers sST2, Galectin-3, GDF-15 and Fetuin-A in patients with peripheral artery disease

Event: ESC CONGRESS 2017

Topic: Pathophysiology, epidemiology

Session: Vascular diseases

Access

0

Doctor Peter Jirak

Contributor content

C - reactive protein is a promising indicator of ventricular arrhythmias in pacemaker patients

Higher incidence of stroke in severe COVID-19 is not associated with a higher burden of arrhythmias: Comparison to other types of severe pneumonia

Changes in micro-RNA secretion patterns following an anti-CD3 and ATG treatment regulate expression of adherens junctions in PBMCs

Analysis of novel cardiac markers sST2 and IL-33 in chronic heart failure with reduced ejection fraction

Differences in the expression of the novel cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in HFpEF, ICM and DCM patients

A comparative analysis of novel biomarkers in sepsis and cardiovascular disease

A comparative analysis of the novel cardiac biomarkers sST2, GDF-15, Galectin-3, suPAR, H-FABP and Fetuin-A in heart failure, STEMI and NSTEMI patients

A comparative analysis of novel cardiac biomarkers (sST2, GDF-15, Galectin-3, suPAR, H-FABP and Fetuin-A) in patients with heart failure, STEMI and controls without cardiovascular disease

Analysis of the novel cardiac biomarkers ST2, GDF-15, suPAR, H-FABP and Fetuin A in heart failure with reduced ejection fraction

Analysis of the novel cardiac biomarkers sST2, Galectin-3, GDF-15 and Fetuin-A in patients with peripheral artery disease

This platform is supported by